Co-diagnostics, inc. receives ce markings for "abc" and sars-cov-2 2-gene multiplex tests

Salt lake city, nov. 17, 2020 /prnewswire/ -- co-diagnostics, inc. (nasdaq: codx), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that its logix smart™ abc (influenza a/b, sars-cov-2) and its logix smart™...
CODX Ratings Summary
CODX Quant Ranking